Servicios Personalizados
Revista
Articulo
Inglés (pdf)
Artículo en XML
Referencias del artículo
Traducción automática
Enviar artículo por emailIndicadores
Citado por SciELO 
Accesos
Links relacionados
Similares en
SciELO
Compartir
Permalink
Revista mexicana de neurociencia
versión On-line ISSN 2604-6180versión impresa ISSN 1665-5044
Resumen
VELEZ-HUERTA, Jesús et al. Preliminary evaluation of the neuroprotective activity of Cannabidiol in combination with some current medicinal drugs in vitro. Rev. mex. neurocienc. [online]. 2024, vol.25, n.4, pp.93-101. Epub 15-Oct-2024. ISSN 2604-6180. https://doi.org/10.24875/rmn.24000002.
Objective:
The objective of this study was to evaluate the neurotoxicity and neuroprotective activity of cannabidiol (CBD), valproate, furosemide, metformin, and bilobalide, individually and mixed with CBD in PC12 cells exposed to Glutamate. In addition, antioxidant activity, reactive oxygen species (ROS) production, and caspase-3 activity were evaluated.
Methods:
Neurotoxicity and neuroprotection were evaluated with the MTT assay; antioxidant activity, and production of ROS with 2,2-diphenyl-1-picryl-hydrazyl-hydrate, and DCFDA methods, respectively; the apoptosis with caspase-3 activity assay.
Results:
CBD 5 μM, and bilobalide 15.3 μM showed neuroprotective activity by ROS inhibition and decreased caspase-3 activity. Metformin 1548.4 μM did not provide significant neuroprotection but decreased ROS generation.
Conclusions:
Combining CBD with the study drugs did not improve neuroprotection than the neuroprotection of individual drugs.
Palabras llave : Cannabidiol; Neuroprotection; Cell death.
